Compare SPRY & AWF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SPRY | AWF |
|---|---|---|
| Founded | 2015 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 920.1M |
| IPO Year | 2020 | N/A |
| Metric | SPRY | AWF |
|---|---|---|
| Price | $9.19 | $10.55 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 275.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.57% |
| EPS Growth | ★ 114.04 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $89,149,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $119.97 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 297063.34 | N/A |
| 52 Week Low | $6.66 | $9.30 |
| 52 Week High | $18.63 | $11.43 |
| Indicator | SPRY | AWF |
|---|---|---|
| Relative Strength Index (RSI) | 42.29 | 39.88 |
| Support Level | $8.61 | $10.55 |
| Resistance Level | $10.44 | $10.74 |
| Average True Range (ATR) | 0.50 | 0.05 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 35.48 | 8.57 |
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
Alliancebernstein Glb High Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its primary investment objective is to seek high current income, and secondarily, capital appreciation. The fund invests in debt securities, including Sovereign Debt Obligations and corporate debt, denominated in non-U.S. currencies as well as in the U.S. Dollar. It may invest without limit in emerging and developed markets and debt securities of U.S. and non-U.S. corporate issuers.